In recent years S100-B has been reported to have a very high specificity for death (95% to 98%) and unfavourable neurological outcomes (85 to 98%) [34], and a very high sensitivity for the diagnosis of brain lesions (99 to 100%) [16,35] in traumatic brain injury. This evidence concerns the gene S100B and injury.